Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Andrew Symons

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
American Journal of Ophthalmology|June 14, 2020
Prognostic Utility of Optical Coherence Tomography for Long-Term Visual Recovery Following Pituitary Tumor SurgeryMichael T M Wang, James King, R C Andrew Symons, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
American Journal of Ophthalmology|July 9, 2010
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027Peter K Kaiser, R C Andrew Symons, Syed Mahmood Shah, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiographySyed Mahmood Shah, Sinan Tatlipinar, Edward Quinlan, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
American Journal of Ophthalmology|June 14, 2020
Prognostic Utility of Optical Coherence Tomography for Long-Term Visual Recovery Following Pituitary Tumor SurgeryMichael T M Wang, James King, R C Andrew Symons, et al.
American Journal of Ophthalmology|December 7, 2007
Intravenous bevacizumab causes regression of choroidal neovascularization secondary to diseases other than age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
American Journal of Ophthalmology|July 9, 2010
RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027Peter K Kaiser, R C Andrew Symons, Syed Mahmood Shah, et al.
Investigative Ophthalmology & Visual Science|November 24, 2006
Dynamic and quantitative analysis of choroidal neovascularization by fluorescein angiographySyed Mahmood Shah, Sinan Tatlipinar, Edward Quinlan, et al.
Pageof 3